The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-γ in colitis

Sato, Akira; Kayama, Hisako; Shojima, Kensaku; Matsumoto, Shinji; Koyama, Hirofumi; Minami, Yasuhiro; Nojima, Satoshi; Morii, Eiichi; Honda, Hiroaki; Takeda, Kiyoshi; Kikuchi, Akira

doi:10.1038/srep10536

Download PDF

Article
Open access
Published: 01 June 2015

The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-γ in colitis

Akira Sato¹,
Hisako Kayama²,
Kensaku Shojima¹,
Shinji Matsumoto¹,
Hirofumi Koyama¹^nAff6,
Yasuhiro Minami⁵,
Satoshi Nojima³,
Eiichi Morii³,
Hiroaki Honda⁴,
Kiyoshi Takeda² &
…
Akira Kikuchi¹

Scientific Reports volume 5, Article number: 10536 (2015) Cite this article

5155 Accesses
50 Citations
2 Altmetric
Metrics details

Subjects

Abstract

Wnt5a, which regulates various cellular functions in Wnt signaling, is involved in inflammatory responses, however the mechanism is not well understood. We examined the role of Wnt5a signaling in intestinal immunity using conditional knockout mice for Wnt5a and its receptor Ror2. Removing Wnt5a or Ror2 in adult mice suppressed dextran sodium sulfate (DSS)-induced colitis. It also attenuated the DSS-dependent increase in inflammatory cytokine production and decreased interferon-γ (IFN-γ)-producing CD4⁺ Th₁ cell numbers in the colon. Wnt5a was highly expressed in stromal fibroblasts in ulcerative lesions in the DSS-treated mice and inflammatory bowel disease patients. Dendritic cells (DCs) isolated from the colon of Wnt5a and Ror2 deficient mice reduced the ability to differentiate naïve CD4⁺ T cells to IFN-γ-producing CD4⁺ Th₁ cells. In vitro experiments demonstrated that the Wnt5a-Ror2 signaling axis augmented the DCs priming effect of IFN-γ, leading to enhanced lipopolysaccharide (LPS)-induced interleukin (IL)-12 expression. Taken together, these results suggest that Wnt5a promotes IFN-γ signaling, leading to IL-12 expression in DCs and thereby inducing Th₁ differentiation in colitis.

Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids

Article 10 April 2024

Jean-Philippe Auger, Max Zimmermann, … Gerhard Krönke

Immune microniches shape intestinal Treg function

Article Open access 03 April 2024

Yisu Gu, Raquel Bartolomé-Casado, … Fiona Powrie

Distal colonocytes targeted by C. rodentium recruit T-cell help for barrier defence

Article Open access 10 April 2024

Carlene L. Zindl, C. Garrett Wilson, … Casey T. Weaver

Introduction

Wnt5a is a representative ligand that activates the Wnt/β-catenin independent signaling pathway and is one of the most extensively studied ligand in the Wnt family. It plays important roles in the developmental processes of various organs and has postnatal cellular functions^1,2. Wnt5a binds to and internalizes its receptor complex, which consists of Frizzled (Fz), a seven transmembrane receptor and receptor tyrosine kinase-like orphan receptor (Ror) 1 or Ror2, a single transmembrane receptor. Wnt5a binding activates Rho, Rac, protein kinase C and Jun-N-terminal kinase (JNK), thereby regulating the cytoskeleton, cell migration and polarity and gene expression^3,4.

Mice homozygous for a Wnt5a null allele (Wnt5a^−/−) suffer perinatal lethality because of asphyxia⁵. The embryos are truncated caudally, displaying an inability to extend the embryonic anterior-posterior axis. Furthermore, knockout of Wnt5a down-regulates expression of the pro-apoptotic gene Bax and promotes expression of the anti-apoptotic gene Bcl-2, which inhibits apoptosis in CD4⁺CD8⁺ double positive thymocytes, suggesting that Wnt5a plays a role in hematopoietic cell development^6,7. Although there are no gross abnormalities in the post-natal development of Wnt5a heterozygous (Wnt5a^+/−) mice, they have a bone-loss phenotype with decreased trabecular bone mass⁸. Aged Wnt5a^+/− mice have an increased population of B cells and develop myeloid and B-cell leukemia⁹. In addition, it has been suggested that post-natal abnormalities in Wnt5a signaling are involved in inflammatory diseases, as well as cancers¹.

For instance, expression of Wnt5a and Fz5 can be induced through Toll-like receptors (TLR) stimulated by Mycobacterium tuberculosis (M. tuberculosis) or lipopolysaccharide (LPS) in macrophages and Wnt5a signaling is involved in producing pro-inflammatory cytokines, such as interleukin (IL)-12 and IL-6^10,11,12. Wnt5a has been detected in granulomatous lesions in the lungs of patients with M. tuberculosis, bone marrow macrophages in septic patients and macrophages accumulated within the intima of atherosclerotic patients^10,11,13. Thus, these results suggest that Wnt5a released from macrophages in response to inflammatory cues affects macrophages in an autocrine manner to release cytokines. However, the underlying mechanism by which Wnt5a regulates inflammation remains enigmatic. Although purified Wnts are useful tools to better understand the roles of Wnt signaling in the inflammatory responses, it has been reported that recombinant Wnt preparations contain TLR agonists that may lead to inflammatory cytokine production¹⁴. Therefore, further in vivo studies elucidating the roles of Wnt5a signaling in the immune responses using adult Wnt5a knockout mice are necessary.

Interferon-γ (IFN-γ) is a key immunoregulatory protein that plays a major role in the host innate and adaptive immune responses¹⁵. IFN-γ is mainly produced in Th₁ cells, which are differentiated from naïve T cells by IL-12 released from antigen-presenting cells, including dendritic cells (DCs) and macrophages^15,16. Engagement of IFN-γ with its receptor leads to the activation of Janus kinase (JAK) and the phosphorylation of signal transducer and activator of transcription (STAT)-1^17,18. STAT1 then translocates into the nucleus where it binds to DNA and initiates the transcription of the STAT1 target genes. IFN-γ also has a priming function and increases inflammatory cytokine production, including tumor necrosis factor-α (TNF-α), IL-6 and IL-12, in response to TLR ligands in DCs and macrophages^15,16. Thus, it appears that IFN-γ and IL-12 form a signaling circuit between Th₁ cells and antigen-presenting cells.

Here we use dextran sodium sulfate (DSS)-induced colitis in mice as a model for inflammatory diseases and show that disease symptoms were milder in Wnt5a and Ror2 conditional knockout mice than control mice. Blocking Wnt5a signaling also reduced the production of pro-inflammatory cytokines in the colon. Finally, we demonstrate that the Wnt5a-Ror2 axis enhances the priming action of IFN-γ to increase TLR-dependent production of IL-12 in DCs, thereby promoting immune responses.

Results

Wnt5a knockout mice were less susceptible to DSS-induced colitis

Given that Wnt5a^−/− mice suffer perinatal lethality⁵, we generated Wnt5a^flox/flox (Wnt5a^fl/fl) mice (Figures S1A-C), in which exon 2 of the Wnt5a gene was flanked by loxP sites. These mice were crossed with different Cre-expressing mice, including CAG-Cre/ERT2^Tg mice and the offspring were treated with DSS. CAG-Cre/ERT2^Tg mice show ubiquitous expression of Cre/ERT2 which is activated by administration of tamoxifen¹⁹. In the Wnt5a^fl/fl;CAG-Cre/ERT2^Tg mice, Wnt5a exon2 was deleted in the colon by administering tamoxifen (Wnt5a^CAGΔ/Δ mice) (Figure S1D). Wnt5a mRNA expression levels varied between Wnt5a^fl/fl mouse tissues, but it was remarkably lower in the liver and bone marrow than other tissues (Fig. 1a). In Wnt5a^CAGΔ/Δmice, Wnt5a mRNA was dramatically decreased in the colon, small intestine, stomach, bone marrow, heart, muscle and brain; and expression was reduced by half in the liver, spleen, thymus and lung (Fig. 1b).

DSS (2.5%) was delivered in drinking water to Wnt5a^CAGΔ/Δmice and their Wnt5a^fl/fl littermates. Wnt5a^CAGΔ/Δmice showed less weight loss than the WT mice following colitis induction (Fig. 2a). DSS caused bleeding in the stools (Fig. 2b) and pasty stools (Fig. 2c) at 5–6 days after its administration. These phenotypes were observed later and to a lesser degree in Wnt5a^CAGΔ/Δmice (Fig. 2b,c). The overall severity of colitis measured as the disease activity index (DAI), which included scores for body weight loss, occult and gross stool bleeding and stool consistency, was milder in Wnt5a^CAGΔ/Δmice than Wnt5a^fl/fl mice (Fig. 2d). These results suggested that Wnt5a^CAGΔ/Δmice were less susceptible to DSS-induced colitis.

The histological patterns in the colon of DSS-fed mice were classified into 4 categories (Figures S2A-D); (1) intact crypts, (2) decreased crypt lesions, (3) monolayer lesions and (4) ulcer lesions. In WT mice, the frequencies of decreased crypt, monolayer and ulcer lesions increased gradually over 5 days of DSS administration (Figure S2E). However, the histopathological scores of epithelium damage were reduced in the DSS-fed Wnt5a^CAGΔ/Δ mice compared with Wnt5a^fl/fl mice (Fig. 2e and Figure. S2F). Although several Wnt mRNAs, including Wnt1, Wnt4, Wnt5a, Wnt5b, Wnt6, and Wnt11, were expressed in the colon, Wnt5a mRNA was expressed more highly than other Wnt mRNAs and significantly increased by DSS administration (Fig. 2f). Thus, Wnt5a might be involved in DSS-induced colitis.

Wnt5a was required for inflammatory cytokine production in the colon

Many ulcer lesions were observed in the area within a 1 cm distance from the anus in DSS-induced colitis. In the lesions of Wnt5a^fl/fl mice, DSS treatment induced increased mRNA expression levels of IL-6, TNF-α, IL-12a, IL-12b and IFN-γ (Fig. 3a). The increases were suppressed in the colon of Wnt5a^CAGΔ/Δ mice (Fig. 3a). The mRNA levels of IL-17a, IL-10 and transforming growth factor-β1 (TGF-β1) were increased in the colons of both Wnt5a^fl/fl and Wnt5a^CAGΔ/Δmice by DSS treatment, but their expression levels were not significantly reduced in Wnt5a^CAGΔ/Δ mice (Fig. 3a). The IL-23a mRNA level was not changed in the colon of DSS-fed Wnt5a^fl/fl and Wnt5a^CAGΔ/Δ mice (Fig. 3a). Enzyme-linked immunosorbent assay (ELISA) confirmed that DSS-induced production of IL-6 and TNF-α was decreased in the Wnt5a^CAGΔ/Δ mouse colon and that production of IL-10, IL-17A and IL-23A was not changed in Wnt5a^CAGΔ/Δ and Wnt5a^fl/fl mice (Fig. 3b). These results suggested that DSS-induced pro-inflammatory cytokine synthesis in the colon was decreased in Wnt5a^CAGΔ/Δ mice compared with control Wnt5a^fl/fl mice.

It is thought that intestinal inflammation is caused by an imbalance between the inflammatory response and tolerance^20,21. Therefore, the frequencies of CD4⁺ Th₁, Th₁₇ and T_reg cells in various tissues were compared in Wnt5a^fl/fl and Wnt5a^CAGΔ/Δ mice. In the colon, Wnt5a^CAGΔ/Δ mice had reduced frequencies of IFN-γ-producing cells (Th₁ cells) compared with Wnt5a^fl/fl mice in the absence or presence of DSS treatment (Fig. 3c,d). In contrast, the frequency of IL-10-producing T cells (T_reg cells) was slightly, not significantly, decreased and the frequency of IL-17-producing T cells (Th₁₇ cells) was not affected by Wnt5a deletion (Fig. 3c,d). In the small intestine, although the frequency of Th₁₇ cells was slightly, not significantly, decreased by Wnt5a deletion, the frequencies of others were not affected (Figure S3A). Loss of Wnt5a did not affect the frequencies of Th₁, Th₁₇ and T_reg cells in the mesenteric lymph nodes, spleen and thymus (Figure S3B). These results suggested that Wnt5a deficiency suppresses Th₁ polarization process, including T cell recruitment and differentiation^22,23, in the colon, thereby attenuating DSS-induced colitis. However, it is unlikely that T cell recruitment from the mesenteric lymph nodes to the colon was decreased in Wnt5a^CAGΔ/Δ mice, because the number of total CD4⁺ T cells in the colon and the mesenteric lymph nodes was not changed between Wnt5a^fl/fl and Wnt5a^CAGΔ/Δmice (Figure S3C). The number of Th₁ cells was reduced in the colon of Wnt5a^CAGΔ/Δ mice rather than that of Wnt5a^fl/flmice, whereas that of T cells was not increased in the mesenteric lymph nodes (Figure S3C). Therefore, Wnt5a might be involved in Th₁ differentiation.

Loss of Wnt5a in the bone marrow and intestinal epithelium did not affect DSS-induced colitis

Given that LPS induces Wnt5a expression in bone marrow cells and macrophages and that Wnt5a alters DC responses to LPS^10,11,24, we first speculated that the inhibition of DSS-induced colitis might be caused by the loss of Wnt5a in hematopoietic cells. To address this question, Wnt5a^fl/fl;Mx-Cre^Tg mice were generated. Mx-Cre mainly deletes genes in hematopoietic cells²⁵. In these mice Wnt5a mRNA expression levels were decreased in the liver, thymus and bone marrow by the peritoneal administration of polyinosine-polycytosine (pIpC) (Wnt5a^MxΔ/Δ mice) (Fig. 1b). Genomic DNA isolated from the bone marrow of Wnt5a^MxΔ/Δ mice showed efficient digestion of Wnt5a exon2 compared with that of Wnt5a^fl/fl mice (Figure S4A). However, the Wnt5a^MxΔ/Δ mice had colitis phenotypes that were similar in terms of severity to Wnt5a^fl/fl mice (Figures S4B and C).

Villin-Cre depletes genes in the epithelial cells of the intestines²⁶. In Wnt5a^fl/fl;Villin-Cre^Tg mice (Wnt5a^VilΔ/Δ mice), Wnt5a genomic DNA was digested in the colon (Figure S4D). However, the reduction of Wnt5a mRNA in the colon was not clearly observed (Figure S4D), likely because Wnt5a might be mainly expressed in the regions other than epithelium of the colon. The clinicopathological symptoms of DSS-induced colitis in the Wnt5a^VilΔ/Δ mice were unchanged compared with Wnt5a^fl/fl mice (Figures S4E and F). Thus, the Wnt5a, if any, released from hematopoietic and intestinal epithelial cells could not be involved in colitis and Wnt5a produced in other cells may play roles in colitis.

Ror2 deficient mice were also less susceptible to DSS-induced colitis

Ror2 is one of the receptors for Wnt5a. Ror2^−/− mice are embryonic lethal and display phenotypes similar to Wnt5a^−/− mice²⁷. To examine whether Ror2 is involved in DSS-induced colitis, Ror2^fl/fl;CAG-Cre/ERT2^Tg and Ror2^fl/fl;Mx-Cre^Tg mice were administrated tamoxifen (Ror2^CAGΔ/Δ) and pIpC (Ror2^MxΔ/Δ), respectively and then DSS was administrated to these mice. Ror2 mRNA was variably expressed in Ror2^fl/fl mouse tissues, but the liver, thymus and muscle had the lowest expression levels (Fig. 1c). Ror2 mRNA expression was reduced in most tissues of Ror2^CAGΔ/Δ mice and especially in the liver, bone marrow and heart of the Ror2^MxΔ/Δ mice (Fig. 1d). Compared with the Ror2^fl/fl mice, both types of Ror2 conditional knockout mice exhibited milder signs and pathological changes following DSS-induced colitis (Fig. 4a,b). The histopathological scores of epithelium damage were also reduced in the DSS-fed Ror2^MxΔ/Δmice compared with Ror2^fl/fl mice (Fig. 4c and Figure. S2G). It is noteworthy that Ror2^MxΔ/Δ mice suppressed DSS-induced colitis in contrast to Wnt5a^MxΔ/Δ mice. The production of pro-inflammatory cytokines, including IL-6 and TNF-α, was suppressed in the colon of Ror2^MxΔ/Δ mice, similar to the Wnt5a^CAGΔ/Δ mice (Fig. 4d,e). Taken together, these results suggested that Ror2 in hematopoietic cells was involved in progression of DSS-induced colitis.

Wnt5a was released primarily from fibroblasts and Ror2 was expressed in DCs in the colon

To examine which cells are the major source of Wnt5a, the colons from mice fed with DSS were analyzed for Wnt5a expression. Wnt5a mRNA was expressed in fibroblasts more highly than epithelial cells and hematopoietic cells, including CD4⁺ T cells, B220⁺ B cells, CD11c⁺ DCs, CD11b⁺CD11c⁻ macrophages and γδT cells in the colon and its expression level was elevated only in the fibroblasts after DSS administration (Figure S5A). In DSS-fed mice, Wnt5a protein and Wnt5a mRNA were not detected in the intact crypt regions of the colon, whereas the protein and mRNA were clearly visible in the mesenchyme of the ulcer lesions (Fig. 5a and Figure. S6). Wnt5a-expressing cells were positive for vimentin (a mesenchymal cell marker), but not for F4/80 (a macrophage marker) and CD11c (a DC marker) (Fig. 5b), suggesting that they were fibroblasts. In addition, Wnt5a was still expressed in the mesenchyme of ulcer lesions in Wnt5a^MxΔ/Δ mice but not in Wnt5a^CAGΔ/Δ mice (Fig. 5c). Taken together, these results suggested that Wnt5a secreted from cells other than hematopoietic cells, probably fibroblasts, affects DSS-induced colitis.

Wnt5a expression was then examined in the colon from Crohn’s disease (9 cases) and ulcerative colitis (10 cases) patients. Wnt5a was not detected in the intact crypt regions (E-cadherin positive) (Fig. 5d), but it was clearly detected in the mesenchyme of ulcer lesions (E-cadherin negative) in about half of the inflammatory bowel disease cases (Fig. 5e). As in the mice, the Wnt5a was detected in vimentin-positive cells but not in the cells expressing CD68, a macrophage and monocyte marker (Fig. 5f,g).

In contrast to Wnt5a, Ror2 mRNA was expressed in hematopoietic cells although it was lower than in fibroblasts (Figure S5B). Among hematopoietic cells, DCs as well as B cells, macrophages and γδT cells, showed higher Ror2 mRNA expression compared with T cells. However, DSS treatment reduced Ror2 mRNA expression in B and γδT cells (Figure S5B), suggesting that these cells are hard to respond to Wnt5a in DSS-induced colitis. In addition, cell numbers of γδT cells were not changed between Wnt5a^CAGΔ/Δ, Ror2^MxΔ/Δ and their control mice irrespective of the presence or the absence of DSS treatment (Figure S7). Taken together with the observations that γδT cells play a role in protections against DSS-induced colitis²⁸, DCs might respond to Wnt5a in colitis rather than B, T and γδT cells.

Intestinal DC subsets have been identified by the combination and expression levels of specific cell surface antigens and characterized by their functions in immune responses^29,30. We classified CD11c⁺ DCs into three subsets, including CD11c⁺CD11b⁻CD103⁺ cells that induce Th₁ polarization, CD11c⁺CD11b⁺CD70⁺CX₃CR1^intermediate cells that induce Th₁₇ polarization and CD11c⁺CD11b⁺ CD70⁺CX₃CR1^high cells that inhibit T cell proliferation^29,30,31,32. The Ror2 mRNA levels varied among subsets and CD11c⁺CD11b⁻CD103⁺ DC cells indeed expressed Ror2 mRNA (Figure S5C) and loss of Wnt5a or Ror2 did not affect total cell numbers of DC subsets in the presence or the absence of DSS treatment (Figure S7). These results suggest that Wnt5a-Ror2 signaling is involved in the activation of intestinal DCs expressing Ror2 rather than their differentiation.

The Wnt5a-Ror2 axis was involved in pro-inflammatory cytokine synthesis in DCs

Intestinal DCs and macrophages play important roles in the regulation of gut homeostasis through induction of helper T cell subsets^20,21. Therefore, intracellular signaling cascades for cytokine productions involved in Th₁ differentiation were examined in DCs. LPS induced the expression of IL-12a, IL-12b, IL-23a and IL-6 mRNA in CD11c⁺ DCs from Wnt5a^fl/fl and Ror2^fl/fl mice (Fig. 6a,b). However, LPS-induced increases in the expression of these cytokines were reduced in DCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice (Fig. 6a,b). Colon CD11c⁺ DCs induces Th₁ differentiation from naïve T cells in vitro^33,34. The ability of DCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice to induce Th₁ differentiation was decreased compared with those from Wnt5a^fl/fl and Ror2^fl/fl mice (Fig. 6c), suggesting that Wnt5a signaling through Ror2 in CD11c⁺ DCs is required for cytokine expression which induces Th₁ differentiation. It is noteworthy that LPS-induced production of IL-12a, IL-12b, IL-23a and IL-6 mRNA was not suppressed in colon CD11c⁺ DCs from Wnt5a^MxΔ/Δ mice (Fig. 6d), which are consistent with the observation that Wnt5a^MxΔ/Δ mice showed the phenotypes similar to control mice in DSS-induced colitis (see Figures S4B and C).

The Wnt/β-catenin pathway in intestinal DCs is required for immunosuppression³⁵. Although Wnt5a has been shown to inhibit the β-catenin pathway^1,4, mRNA expression levels of Axin2, a target gene of β-catenin signaling, did not increase in CD11c⁺ DCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice (Fig. 6a,b). This suggested that the phenotypes induced by Wnt5a and Ror2 deficiency were not due to the activation of the Wnt/β-catenin pathway.

The Wnt5a-Ror2 axis was also involved in functions of bone marrow-derived DCs

To examine the roles of Wnt5a signaling in DC functions further, bone marrow cells were isolated from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice and incubated with granulocyte macrophage colony-stimulating factor (GM-CSF) for 7 days to generate bone marrow-derived DCs (BMDCs). Loss of Wnt5a or Ror2 suppressed IL-12a, IL-12b, IL-23a and IL-6 mRNA expression in BMDCs stimulated with LPS (Fig. 7a,b). Ectopic expression of Wnt5a did not affect the basal levels of IL-12a, IL-12b, IL-23a, IL-6 and IL-10 mRNA expression, but did enhance LPS-induced pro-inflammatory cytokine mRNA expression (Fig. 7c). ELISA confirmed that ectopically expressed Wnt5a promotes LPS-induced secretion of IL-6 and IL-12p40 but not that of IL-10 (Fig. 7d). However, Wnt5a did not affect the expression of CD80 and CD86, which indicate DC maturation, in BMDCs (Figure S8), suggesting that Wnt5a signaling did not affect the phenotype of DCs.

To test whether Wnt5a secreted from other cells affects DC functions, bone marrow cells were cocultured with mouse fibroblast cell lines, L cells stably expressing Wnt5a in the presence of GM-CSF for 7 days. However, this coculture experiment failed, because L cells were detached from dishes after 5 days. Instead, HeLaS3 cells stably expressing Wnt5a (HeLaS3/Wnt5a cells) were used in this experiment (Figure S9A). Knockdown of Wnt5a efficiently reduced both endogenous and exogenous Wnt5a and the phosphorylation of Dishevelled 2 (Dvl2), which indicates the activation of Wnt5a signaling (Figure S9A). HeLaS3 cells neither expressed IL-12 mRNA nor induced IL-6 mRNA in response to LPS regardless of Wnt5a expression levels (Figure S9B). Under these conditions, coculture of bone marrow cells with HeLaS3/Control cells promoted LPS-induced secretion of IL-12p40 and IL-6 in the resultant BMDCs (Fig. 7e), because HeLaS3 cells express Wnt5a endogenously³⁶ (Figure S9A). Coculture with HeLaS3/Wnt5a cells further enhanced it (Fig. 7e). Enhanced secretions of IL-12p40 and IL-6 were suppressed by knockdown of Wnt5a in these HeLaS3 cells (Fig. 7e). Taken together, these results suggested that the Wnt5a-Ror2 axis between non-hematopoietic cells and DCs promoted pro-inflammatory cytokine production in DCs.

The Wnt5a-Ror2 axis promoted the priming action of IFN-γ in DCs

Finally, the mechanism by which Wnt5a promotes inflammation was examined. LPS activates nuclear factor kappa B (NF-κB), JNK and p38 through TLR4 to induce the expression of IL-12, IL-6 and TNF-α in DCs³⁷. When control BMDCs from Wnt5a^fl/fl and Ror2^fl/fl mice were stimulated with LPS, inhibitor of kappa B-α (IκB-α) was degraded to induce the nuclear translocation of the NF-κB p65-subunit (NF-κBp65) and JNK and p38 were also phosphorylated (Figures S10A-D). There were no significant differences in the activation of these signaling pathways in BMDCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice compared with Wnt5a^fl/fl and Ror2^fl/fl mice, respectively (Figures S10A-D). Therefore, the Wnt5a-Ror2 axis might promote LPS-dependent cytokine production without affecting the TLR4 signaling pathway directly.

IL-12 from DCs and macrophages plays a critical role in Th₁ differentiation^15,38 and FACS analyses revealed that IFN-γ-producing Th₁ cells in the colon were decreased in Wnt5a^CAGΔ/Δmice (see Fig. 3c,d). Therefore, the mechanism underlying how the Wnt5a-Ror2 axis affects the transcription of the IL-12b gene in DCs was examined using the chromatin immunoprecipitation (ChIP) assay. LPS induces the recruitment of RNA polymerase II (Pol II) and NF-κBp65 to the IL-12b promoter in macrophages³⁹. Pol II and NF-κBp65 were recruited to the IL-12b promoter region by LPS stimulation in BMDCs from Wnt5a^fl/fl and Ror2^fl/fl mice, but their recruitment was diminished in BMDCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice (Fig. 8a,b). LPS also enhanced histone H4K8-acetylation (H4K8-Ac) at the IL-12b gene in BMDCs from Wnt5a^fl/fl and Ror2^fl/fl mice, which was decreased in BMDCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δmice (Fig. 8a,b). Thus, the Wnt5a-Ror2 axis may enhance LPS-induced transcription of the IL-12b gene in DCs through the formation of Pol II-containing transcription initiation complexes.

IFN-γ primes macrophages for the expression of IL-12b gene^16,40,41. Given that the actions of Wnt5a are similar to the effects of IFN-γ priming, we examined whether the Wnt5a-Ror2 axis affects IFN-γ signaling in DCs. IFN-γ induced the phosphorylation of JAK1 and STAT1 in BMDCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice, but at a lower level than was observed in control BMDCs from Wnt5a^fl/fl and Ror2^fl/fl mice (Fig. 8c,d). In addition, the IFN-γ-induced recruitment of STAT1 to the IL-12b promoter was decreased in BMDCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice compared with their control BMDCs (Fig. 8e,f). However, Src activity, which is involved in the Wnt5a and STAT signaling^42,43, was not changed in BMDCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice (Figures S10E and F). Taken together, these results suggested that the Wnt5a-Ror2 axis enhances the priming action of IFN-γ, although the signaling pathway by which Wnt5a activates to regulate this action is not known at present.

Discussion

Our results support that the Wnt5a-Ror2 axis promotes DSS-induced colitis by enhancing pro-inflammatory cytokine production in the colon. There are two major pathways for Wnt signaling. The first is the β-catenin dependent pathway and the second is the β-catenin independent pathway, which is activated by Wnt5a. The β-catenin dependent pathway is activated in intestinal DCs and is required for the secretion of immunosuppressive cytokines³⁵. Although Wnt5a signaling is able to suppress the β-catenin dependent pathway^1,4, our results showed that the β-catenin dependent pathway was not activated in CD11c⁺ DCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice. Therefore, the β-catenin independent pathway may regulate intestinal inflammatory responses independently of the β-catenin dependent pathway at least in DCs. It is intriguing to speculate that Wnt signaling may trigger anti- or pro-immune responses through the β-catenin dependent or independent pathway, respectively, in intestinal DCs.

The clinical signs, histological damage and pro-inflammatory cytokine levels in DSS-induced colitis were suppressed in Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice compared with control mice. In turn, the Wnt5a^MxΔ/Δ and Wnt5a^VilΔ/Δ mice showed colitis phenotypes similar to control mice. The latter finding suggests that Wnt5a released from hematopoietic cells (Wnt5a^MxΔ/Δ) or epithelial cells (Wnt5a^VilΔ/Δ) in the colon was not involved in DSS-induced colitis. Our results demonstrated that in mice, the basal expression level of Wnt5a in intestinal fibroblasts is much higher than hematopoietic cells or epithelial cells and that DSS administration induces Wnt5a expression in fibroblasts located in ulcer lesions. The observation that LPS-induced pro-inflammatory cytokines produced from CD11c⁺ DCs in Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice were decreased but not in Wnt5a^MxΔ/Δ mice also support that hematopoietic cells are not the primary source of Wnt5a in the colon. In addition, our human studies show that Wnt5a was clearly observed in vimentin-positive cells, but not macrophages, in the ulcer lesions of patients with ulcerative colitis and Crohn’s diseases. Taken together, these results suggest that fibroblasts might be the primary source of Wnt5a at least in the colon during inflammatory bowel disease.

It has been reported that Wnt5a can act in a paracrine manner on neighboring cells. For example, the Wnt5a-Ror2 axis between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis, while Ror2 deficiency in osteoclast precursors leads to impaired osteoclastogenesis⁸. In addition, the Wnt5a-Fz8/Flamingo axis functionally maintains HSCs in their niche through interactions between N-cadherin-positive osteoblasts, which express Wnt ligands including Wnt5a and long-term HSCs that express Fz8 and Flamingo⁴⁴. Similarly, our results suggest that Wnt5a from non-hematopoietic cells (probably fibroblasts) act on DCs, which express Ror2, to promote inflammation in response to infectious cues. However, knockdown of Wnt5a in murine macrophages suppresses the secretion of IFNs in vitro¹². Wnt5a secreted from human DCs is involved in IL-12 secretion in autocrine manner and enhances IFN-γ secretion from CD4⁺ T cells in paracrine manner⁴⁵. Thus, it cannot be excluded the possibility that Wnt5a promotes cytokine production from hematopoietic cells in an autocrine manner, at least in vitro, in different conditions. Intestinal DCs are the first cells recruited to and activated at sites of infection or injury. DCs play an important role in the gut where they continually sample intestinal antigen and participate in inducing distinct immune responses²¹. IL-12 production from DCs in particular is essential for Th₁ differentiation^15,38 and IFN-γ-producing Th₁ cells in the colon were indeed decreased in the Wnt5a^CAGΔ/Δmice in this study. Although it might be possible that the Wnt5a-Ror2 axis is involved in the recruitment of naïve T cells into the colon^22,23, this possibility is unlikely, because the T cell number in the colon was not changed in Wnt5a^fl/fl and Wnt5a^CAGΔ/Δ mice (see Figure S3C). Therefore, our results provided one possible mechanistic link between Wnt5a signaling and DC functions.

Wnt5a reportedly promoted NF-κB signaling through the activation of PKC or Rac in endothelial cells and macrophages^12,46, but this is not the case in DCs. In our study, LPS induced degradation of IκB-α and NF-κBp65 nuclear localization in BMDCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice, as well as BMDCs from control mice. Instead, the Wnt5a-Ror2 axis was required for LPS-induced IL-12 expression by enhancing Pol II recruitment, NF-κBp65 occupancy and histone acetylation. Therefore, it is likely that the Wnt5a-Ror2 axis is involved in promoting chromatin remodeling to increase recruitment of TLR-activated transcription factors at the IL-12b gene. This mechanism of action resembles to that of IFN-γ. As another receptor of Wnt5a, Ryk (related to receptor tyrosine kinase) atypical tyrosine kinase receptor, is involved in Wnt5a signaling-mediated axon guidance^47,48 and Xenopus gastrulation movement⁴⁹ and it is expressed in immature DCs and CD4⁺ T cells⁴⁵. To clarify whether Ryk mediates Wnt5a-dependent immune responses would be necessary for the understanding of roles of Wnt5a signaling in inflammation.

An important function of IFN-γ is to prime DCs and macrophages for synergistic transcription of pro-inflammatory cytokine genes by inflammatory factors, through STAT1 activation^15,16,38. For instance, IFN-γ induces TLR4 dependent transcription factors and RNA polymerase II to occupy cytokine gene promoters and enhancers, thereby increasing expression of TNF-α, IL-6 and IL-12, in macrophages¹⁶. Our results demonstrated that IFN-γ dependent JAK activation and STAT1 phosphorylation were decreased in BMDCs from Wnt5a^CAGΔ/Δ and Ror2^MxΔ/Δ mice. It is possible that the Wnt5a-Ror2 axis promotes the IFN-γ priming action in DCs. Loss of Wnt5a or Ror2 did not affect the expression of JAK1 and STAT1 (see Fig. 8c,d) and the basal levels of IFN-γ receptor1/2 mRNA (data not shown). Thus, Wnt5a-induced expression of other genes might decide the threshold for IFN-γ signaling although the detailed mechanism is not known at present. The reduction in the Th₁ differentiation in Wnt5a^CAGΔ/Δ mice could be due primarily to the decrease in IL-12 production from DCs. IFN-γ is mainly produced by Th₁ cells, natural killer cells and CD8⁺ T cells. IL-12 is important for Th₁ differentiation and IFN-γ synthesis and IFN-γ promotes IL-12 production in DCs. Therefore, the Wnt5a-Ror2 axis would regulate the priming action of IFN-γ and contributes to the signaling circuit between IL-12 and IFN-γ.

Methods

Animals

The protocols used for all animal experiments in this study were approved by the Animal Research Committee of Osaka University, Japan (No. 21–048–1). All animal experiments were carried out according to the guidelines for the care and use of experimental animals of Osaka University. Details of Wnt5a^fl/fl mouse line generation are described in Supplementary Methods. Ror2^fl/fl mice were generated as described⁸. CAG-Cre/ERT2^Tg and Villin-Cre^Tg mice were purchased from Jackson Laboratory. To treat the mice, a stock solution of tamoxifen (4-hydroxitamoxifen; Sigma-Aldrich, St. Louis, MO) in ethanol (150 mg/ml) was diluted in corn oil to 15 mg/ml. The tamoxifen suspension (0.1 ml) was administered to adult Wnt5a^fl/fl or Ror2^fl/fl;CAG-Cre/ERT2^Tg mice 4 weeks of age and relevant control Wnt5a^fl/fl or Ror2^fl/flmice three times at two day intervals to induce the activation of the Cre-ERT2 recombinase and to remove the floxed Wnt5a or Ror2 coding region¹⁹. Mx-Cre expression was induced by the intraperitoneal injection of 500 μg pIpC (Sigma-Aldrich) six times at two day intervals to remove the floxed Wnt5a or Ror2 coding region²⁵. The primers used for genotyping in this study were listed in Supplementary Table S1.

Induction of colitis

DSS was administered to eight to nine weeks old male mice in their drinking water at a final concentration of 2.5% (w/v) to induce colitis. Animals were observed daily for weight, stool consistency and the presence of gross blood in feces and at the anus. Detailed evaluation of colitis is described in Supplementary Methods.

Preparation of colon extraction

After 7 days administration of DSS, 2 cm length of colon from anus was isolated and homogenized in homogenization buffer (25 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM phenylmethylsulfonylfluoride, 1 μg/ml leupeptin, 1 μg/ml aprotinin) by downs homogenizer (15 strokes). After the homogenization, 1% Nonidet P-40, 1% deoxycholic acid and 0.1% sodium dodecyl sulfate (SDS) were added to the homogenates. The homogenates were sonicated 6 times for 15 sec by Ultra S homogenizer (TAITEC, Nagoya, Japan), incubated at 4 ˚C with rotation for 1 h and then centrifuged at 20,000 x g for 10 min. The supernatants were used in ELISA.

Patients and tissues of inflammatory bowel diseases

Tissue samples from 20 patients who underwent surgery for Crohn’s disease and ulcerative colitis at Osaka University Hospital from 2011 to 2013 were examined. Histological specimens were fixed in 10% formalin and routinely processed for paraffin embedding. Paraffin-embedded specimens were stored in the dark room in the Department of Pathology at Osaka University Hospital at room temperature and cut into 4 μm thick sections at the time of staining. The study was approved by the ethics review board of Graduate School of Medicine, Osaka University (No. 13455).

Isolation of lamina propria DCs, bone marrow-derived DCs (BMDCs) and lymphocytes

Isolations of lamina propria DCs, BMDCs and lymphocytes were performed as described by Ueda Y. et al.⁵⁰, Kayama H. et al.⁵¹ and Kusu T. et al.⁵², respectively. Details of experimental procedures are described in Supplementary Methods.

Coculture of naïve CD4⁺ T cells with lamina propria DCs

Coculture of naïve CD4⁺ T cells with lamina propria DCs were performed as described by Atarashi K. et al.⁵³ and Kayama H. et al.⁵¹. Details of experimental procedures are described in Supplementary Methods.

General experimental procedures

General experimental procedures are described in Supplementary Methods.

Statistical analysis

The experiments in each figure were performed three to four times and differences between control and experimental groups were evaluated using the Student’s t-test and a one-way ANOVA with a Bonferroni test for multiple group comparison. A P value < 0.05 was considered a significant difference.

Others

Quantification data was calculated based on at least three blots or gels from different experiments. All the gels were run under the same experimental condition as detailed in the Supplementary Methods.

Additional Information

How to cite this article: Sato, A. et al. The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-γ in colitis. Sci. Rep. 5, 10536; doi: 10.1038/srep10536 (2015).

References

Kikuchi, A., Yamamoto, H., Sato, A. & Matsumoto, S. Wnt5a: its signalling, functions and implication in diseases. Acta Physiol. (Oxf) 204, 17–33 (2012).
Article CAS Google Scholar
Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon. Functions and mechanisms of β-catenin-independent Wnt signaling. Dev. Cell 5, 367–377 (2003).
Article CAS PubMed Google Scholar
Nishita, M., Enomoto, M., Yamagata, K. & Minami, Y. Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells. Trends Cell Biol. 20, 346–354 (2010).
Article CAS PubMed Google Scholar
Sato, A., Yamamoto, H., Sakane, H., Koyama, H. & Kikuchi, A. Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J. 29, 41–54 (2010).
Article CAS PubMed Google Scholar
Yamaguchi, T. P., Bradley, A., McMahon, A. P. & Jones, S. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126, 1211–1223 (1999).
CAS PubMed Google Scholar
Liang, H. et al. Noncanonical Wnt signaling promotes apoptosis in thymocyte development. J. Exp. Med. 204, 3077–3084 (2007).
Article CAS PubMed PubMed Central Google Scholar
Staal, F. J., Luis, T. C. & Tiemessen, M. M. WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 8, 581–593 (2008).
Article CAS PubMed Google Scholar
Maeda, K. et al. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat. Med. 18, 405–412 (2012).
Article CAS PubMed Google Scholar
Liang, H. et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4, 349–360 (2003).
Article CAS PubMed Google Scholar
Blumenthal, A. et al. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108, 965–973 (2006).
Article CAS PubMed Google Scholar
Pereira, C., Schaer, D. J., Bachli, E. B., Kurrer, M. O. & Schoedon, G. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler. Thromb. Vasc. Biol. 28, 504–510 (2008).
Article CAS PubMed Google Scholar
Naskar, D. et al. Wnt5a-Rac1-NF-κB homeostatic circuitry sustains innate immune functions in macrophages. J. Immunol. 192 4386–4397 (2014).
Article CAS PubMed Google Scholar
Christman, M. A., 2nd et al. Wnt5a is expressed in murine and human atherosclerotic lesions. Am. J. Physiol. Heart Circ. Physiol. 294, H2864–2870 (2008).
Article CAS PubMed Google Scholar
Yu, C. H. et al. Recombinant Wnt3a and Wnt5a elicit macrophage cytokine production and tolerization to microbial stimulation via Toll-like receptor 4. Eur. J. Immunol. 44, 1480–1490 (2014).
Article CAS PubMed Google Scholar
Hu, X. & Ivashkiv, L. B. Cross-regulation of signaling pathways by interferon-γ: implications for immune responses and autoimmune diseases. Immunity 31, 539–550 (2009).
Article CAS PubMed PubMed Central Google Scholar
Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and Toll-like receptor signaling. Immunity 39, 454–469 (2013).
Article CAS PubMed Google Scholar
Stark, G. R. How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev. 18, 419–423 (2007).
Article CAS PubMed PubMed Central Google Scholar
Schindler, C., Levy, D. E. & Decker, T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282, 20059–20063 (2007).
Article CAS PubMed Google Scholar
Hayashi, S. & McMahon, A. P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244, 305–318 (2002).
Article CAS PubMed Google Scholar
Garrett, W. S., Gordon, J. I. & Glimcher, L. H. Homeostasis and inflammation in the intestine. Cell 140, 859–870 (2010).
Article CAS PubMed PubMed Central Google Scholar
Kayama, H. & Takeda, K. Regulation of intestinal homeostasis by innate and adaptive immunity. Int. Immunol. 24, 673–680 (2012).
Article CAS PubMed Google Scholar
Koboziev, I., Karlsson, F. & Grisham, M. B. Gut-associated lymphoid tissue, T cell trafficking and chronic intestinal inflammation. Ann. N Y Acad. Sci. 1207 Suppl 1 E86–93 (2010).
Article ADS PubMed PubMed Central Google Scholar
von Andrian, U. H. & Mempel, T. R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3, 867–878 (2003).
Article CAS Google Scholar
Oderup, C., LaJevic, M. & Butcher, E. C. Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance. J. Immunol. 190, 6126–6134 (2013).
Article CAS PubMed PubMed Central Google Scholar
Kuhn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427–1429 (1995).
Article ADS CAS PubMed Google Scholar
Madison, B. B. et al. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277, 33275–33283 (2002).
Article CAS PubMed Google Scholar
Takeuchi, S. et al. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells 5, 71–78 (2000).
Article CAS PubMed Google Scholar
Chen, Y., Chou, K., Fuchs, E., Havran, W. L. & Boismenu, R. Protection of the intestinal mucosa by intraepithelial γδT cells. Proc. Natl. Acad. Sci. USA 99, 14338–14343 (2002).
Article ADS CAS PubMed Google Scholar
Niess, J. H. What are CX3CR1⁺ mononuclear cells in the intestinal mucosa? Gut Microbes 1, 396–400 (2010).
Article PubMed PubMed Central Google Scholar
Bekiaris, V., Persson, E. K. & Agace, W. W. Intestinal dendritic cells in the regulation of mucosal immunity. Immunol. Rev. 260, 86–101 (2014).
Article CAS PubMed Google Scholar
Fujimoto, K. et al. A new subset of CD103⁺CD8α⁺ dendritic cells in the small intestine expresses TLR3, TLR7 and TLR9 and induces Th1 response and CTL activity. J. Immunol. 186, 6287–6295 (2011).
Article CAS PubMed Google Scholar
Kayama, H. et al. Intestinal CX3C chemokine receptor 1^high (CX3CR1^high) myeloid cells prevent T-cell-dependent colitis. Proc. Natl. Acad. Sci. USA 109, 5010–5015 (2012).
Article ADS CAS PubMed Google Scholar
Karlis, J. et al. Characterization of colonic and mesenteric lymph node dendritic cell subpopulations in a murine adoptive transfer model of inflammatory bowel disease. Inflamm. Bowel Dis. 10, 834–847 (2004).
Article PubMed Google Scholar
Krajina, T., Leithauser, F., Moller, P., Trobonjaca, Z. & Reimann, J. Colonic lamina propria dendritic cells in mice with CD4⁺ T cell-induced colitis. Eur. J. Immunol. 33, 1073–1083 (2003).
Article CAS PubMed Google Scholar
Manicassamy, S. et al. Activation of β-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329, 849–853 (2010).
Article ADS CAS PubMed PubMed Central Google Scholar
Sakane, H., Yamamoto, H., Matsumoto, S., Sato, A. & Kikuchi, A. Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling. J. Cell Sci. 125, 449–460 (2012).
Article CAS PubMed Google Scholar
Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–511 (2004).
Article CAS PubMed Google Scholar
Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133–146 (2003).
Article CAS PubMed Google Scholar
Kayama, H. et al. Class-specific regulation of pro-inflammatory genes by MyD88 pathways and IκBζ. J. Biol. Chem. 283, 12468–12477 (2008).
Article CAS PubMed Google Scholar
Hayes, M. P., Wang, J. & Norcross, M. A. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 86, 646–650 (1995).
CAS PubMed Google Scholar
Ma, X., Neurath, M., Gri, G. & Trinchieri, G. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J. Biol. Chem. 272, 10389–10395 (1997).
Article CAS PubMed Google Scholar
Shojima, K. et al. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively. Sci. Rep. 5, 8042 (2015).
Article CAS PubMed PubMed Central Google Scholar
Gujral, T. S. et al. A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis. Cell 159, 844–856 (2014).
Article CAS PubMed PubMed Central Google Scholar
Sugimura, R. et al. Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell 150, 351–365 (2012).
Article CAS PubMed PubMed Central Google Scholar
Valencia, J. et al. Wnt5a signaling increases IL-12 secretion by human dendritic cells and enhances IFN-γ production by CD4⁺ T cells. Immunol. Lett. 162, 188–199 (2014).
Article CAS PubMed Google Scholar
Kim, J. et al. Wnt5a induces endothelial inflammation via β-catenin-independent signaling. J. Immunol. 185, 1274–1282 (2010).
Article CAS PubMed Google Scholar
Yoshikawa, S., McKinnon, R. D., Kokel, M. & Thomas, J. B. Wnt-mediated axon guidance via the Drosophila Derailed receptor. Nature 422, 583–588 (2003).
Article ADS CAS PubMed Google Scholar
Keeble, T. R. et al. The Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the contralateral side of the corpus callosum. J. Neurosci. 26, 5840–5848 (2006).
Article CAS PubMed PubMed Central Google Scholar
Lin, S., Baye, L. M., Westfall, T. A. & Slusarski, D. C. Wnt5b-Ryk pathway provides directional signals to regulate gastrulation movement. J. Cell Biol. 190, 263–278 (2010).
Article CAS PubMed PubMed Central Google Scholar
Ueda, Y. et al. Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. Int. Immunol. 22, 953–962 (2010).
Article CAS PubMed Google Scholar
Kayama, H. et al. NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection. PLoS Pathog. 5, e1000514 (2009).
Article PubMed PubMed Central Google Scholar
Kusu, T. et al. Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine. J Immunol 190, 774–783 (2013).
Article CAS PubMed Google Scholar
Atarashi, K. et al. ATP drives lamina propria TH17 cell differentiation. Nature 455, 808–812 (2008).
Article ADS CAS PubMed Google Scholar

Download references

Acknowledgements

We thank Dr. J. Takeda and the RIKEN BioResource Center in Japan for providing us with KY1.1 ES cells and B6-Tg(CAG-FLPe)36 mice (RBRC01834). We are grateful to Drs. T. Harada, Y. Kudo, M. Yamamoto, M. Murakami, M. Ohshima and N. Oue for technical assistance. We thank Dr. Y. Hori for preparing human inflammatory bowel disease (IBD) samples. We also thank Dr. R. Nishinakamura, M. Nishita and all of our laboratory members for helpful discussions. This work was supported by awards from Grants-in-Aid for Scientific Research to A.K. (2009–2011; No. 21249017 and 2013–2014; No. 25250018) and A.S. (2012–2014; No.24590378) and an award from Scientific Research on Innovative Areas to A.K. (2011–2014; No. 23112004).

Author information

Hirofumi Koyama
Present address: Department of Biochemistry and Genetics, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan

Authors and Affiliations

Departments of Molecular Biology and Biochemistry,
Akira Sato, Kensaku Shojima, Shinji Matsumoto, Hirofumi Koyama & Akira Kikuchi
Microbiology and Immunology, and,
Hisako Kayama & Kiyoshi Takeda
Pathology, Graduate School of Medicine, Osaka University,, 2-2 Yamadaoka, Suita, 565-0871, Japan
Satoshi Nojima & Eiichi Morii
Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan
Hiroaki Honda
Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, 7-5-1 Kusunoki-cho, Chuoh-ku, Kobe, 650-0017, Japan
Yasuhiro Minami

Authors

Akira Sato
View author publications
You can also search for this author in PubMed Google Scholar
Hisako Kayama
View author publications
You can also search for this author in PubMed Google Scholar
Kensaku Shojima
View author publications
You can also search for this author in PubMed Google Scholar
Shinji Matsumoto
View author publications
You can also search for this author in PubMed Google Scholar
Hirofumi Koyama
View author publications
You can also search for this author in PubMed Google Scholar
Yasuhiro Minami
View author publications
You can also search for this author in PubMed Google Scholar
Satoshi Nojima
View author publications
You can also search for this author in PubMed Google Scholar
Eiichi Morii
View author publications
You can also search for this author in PubMed Google Scholar
Hiroaki Honda
View author publications
You can also search for this author in PubMed Google Scholar
Kiyoshi Takeda
View author publications
You can also search for this author in PubMed Google Scholar
Akira Kikuchi
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

A.S. designed the experiments, carried out the mouse and cell level experiments and wrote the manuscript. H.K. and K.T. designed the immunological experiments and H.K. carried out the FACS analysis. K.S. and S.M. carried out the histological and immunohistochemical experiments. H.K. and H.H. generated the Wnt5a floxed mice. Y.M. generated the Ror2 floxed mice. S.N. and E.M. provided human IBD samples and analyzed them. A.K. designed experiments and wrote the manuscript.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Electronic supplementary material

Supplementary Information

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0

Reprints and permissions

About this article

Cite this article

Sato, A., Kayama, H., Shojima, K. et al. The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-γ in colitis. Sci Rep 5, 10536 (2015). https://doi.org/10.1038/srep10536

Download citation

Received: 09 December 2014
Accepted: 23 April 2015
Published: 01 June 2015
DOI: https://doi.org/10.1038/srep10536

This article is cited by

cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection
- Jorgelina M. Calandria
- Khanh V. Do
- Nicolas G. Bazan
Cellular and Molecular Neurobiology (2023)
Investigation on the Inhibitory Effect of Wnt-5a on Colonic Mucosal Inflammation in Patients with Ulcerative Colitis
- Kazuhiko Uchiyama
- Tomohisa Takagi
- Yoshito Itoh
Digestive Diseases and Sciences (2022)
Conflicting Effects of Wnt-5a in Ulcerative Colitis: You Wnt Some, You Lose Some
- Mudan Zhang
- Zhuo Xie
- Shenghong Zhang
Digestive Diseases and Sciences (2022)
GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling
- Shinji Matsumoto
- Taku Yamamichi
- Akira Kikuchi
Nature Communications (2019)
Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
- Meliha Mehmeti
- Caroline Bergenfelz
- Karin Leandersson
Communications Biology (2019)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.